Algo version: 0.98b
Tianjin Pharmaceutical Da is listed at the EURONEXT Exchange
Tianjin Pharmaceutical Da [T14.SI]
EURONEXT Sector: Healthcare Industry:Drug Manufacturers—Specialty & Generic

Is Tianjin Pharmaceutical Da stock a buy?

What Is The Conclusion?

Right now our advanced algorithms say:

Do the analyst corps agree?

Interesting Questions and Easy Answers!

Yes, Tianjin Pharmaceutical Da pays dividends. Last time was Friday 12th of July 2024 where the investors holding the stock on Tuesday 2nd of July 2024 were paid $0.03272458 per share. Over the last 22 times between 2000 and 2024, Tianjin Pharmaceutical Da has paid $0.36619185 with an average of $0.02 per share.

Sorry, we do not have any analyst data for this ticker

We cannot find data for Tianjin Pharmaceutical Da 10 years ago, but if you had invested on Sunday 8th of September 2019 when the price was $0.805, you would have made a profit of $1.325 per share or 164.60%

No, the average daily trading liquidity for Tianjin Pharmaceutical Da is $94 804 thousand. Trading in stocks with this little trading liquidity is very dangerous, and you can get into a situation where it will be hard to trade your stocks. In addition, these types of stocks usually have very high volatility.

Tianjin Pharmaceutical Da has little of the business financed by loans. This puts the company at lower risk in periods of high inflation where borrowing costs usually go up. With a high cash flow to debt ratio of 0.80, the company's ability to pay off the debt is good. Tianjin Pharmaceutical Da has a good net profit margin of 11.94% and should have high tolerances against inflation.

We have calculated the inflation risk for Tianjin Pharmaceutical Da to be low [0.1 of 1]

US inflation for July 2024 was 0.15%. Over the last 12 months, the US inflation is 2.92%. The 10-year treasury yield that indicates the future interest level is currently 3.72 and is down -0.95 over the last 30 days.